We are the largest network of medical laboratories in Poland, with the widest selection of laboratory tests. Specializes in the implementation of professional services from the collection and transport of biological material, through the examination, to providing the result of medical analysis in the shortest possible time. We service millions of patients each year and work with several thousand health care facilities.
Our company was founded in Krakow in 1998. Within a dozen or so years it has become a leader in the industry, and the seal of dynamic development was the opening in 2014 of the largest in Poland central network laboratory. We carry out 80 million tests annually for over 15 million patients.
As the first laboratory network in the country, we have launched our own laboratory for molecular biology research, and for several years we have been developing a unique offer of autoimmune diagnostics.
Thanks to rigorous quality controls and openness to innovation, we constantly increase the level of services offered.
86.90.E - Other human health activities notelsewhere classified
47.19.Z - Other retail sale in non-specialised stores
49.41.Z - Freight transport by road
68.10.Z - Buying and selling of own real estate
68.20.Z - Rental and operating of own or leased real estate
70.2 - Management consultancy activities
72.1 - Research and experimental development on natural sciences and engineering
73 - Advertising and market research
82.30.Z - Organisation of conventions and trade shows
85.59 - Other education n.e.c.
2017 | 2018 | 2019 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 14,6 | 16,1 | 17,6 | 9,3 |
Liabilities and provisions | 1,4 | 1,6 | 1,7 | 7,4 |
Equity | 10,2 | 10,4 | 10,5 | 0,8 |
Total assets | 11,7 | 12 | 12,2 | 1,7 |
Cash and cash equivalents | 4,3 | 4,3 | 3,8 | -11,5 |
Depreciation | 0,2 | 0,2 | 0,2 | 3,6 |
Gross profit / loss | 4,7 | 4,9 | 4,9 | 1,3 |
EBITDA | 4,7 | 4,9 | 4,9 | -0,6 |
Net profit / loss | 4,7 | 4,9 | 4,9 | 1,3 |
Operating profit (EBIT) | 4,5 | 4,8 | 4,7 | -0,8 |
Current assets | 8,1 | 8,4 | 8,7 | 3 |
% | % | % | p.p. | |
Return on equity (ROE) | 45,9 | 46,9 | 47,1 | 0,2 |
Return on sales (ROS) | 32,3 | 30,4 | 28,2 | -2,2 |
Equity ratio | 87,6 | 86,8 | 86 | -0,8 |
EBITDA margin | 32,2 | 30,7 | 28 | -2,7 |
Gross profit margin | 32,3 | 30,4 | 28,2 | -2,2 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 35 | 34 | 34 | 0 |
Current ratio | 5,8 | 5,6 | 5,3 | -0,3 |
Net debt to EBITDA | -0,9 | -0,9 | -0,8 | 0,1 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.